← All companies
Cullinan Therapeutics, Inc.
CGEM - CIK 0001789972
Market cap$740.57 M
Rank#2664
SEC filings435
The table below shows Cullinan Therapeutics, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $75.08M | $103.33M | $72.82M | $76.66M | $102.08M | $115.02M |
| Short-term investments | $276.80M | $229.26M | $192.66M | $227.17M | $475.99M | $547.47M |
| Receivables | - | - | - | - | - | - |
| Inventory | - | - | - | - | - | - |
| Total current assets |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.